Expand your network before, during, and after the Symposium. Connect with colleagues onsite or via one of the professional networking portals below.
Tweeting about the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium? Use the official Symposium hashtag #immunosym.
Connect with colleagues on Twitter
Follow the #ImmunoSym Featured Voices for expert insights and live updates from the meeting.
View Featured Voices' disclosure information below.
Start a discussion on LinkedIn
Share your experience on Facebook
Discover more on YouTube
Featured Voices Disclosures
All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Consulting or Advisory Role - TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Rinat (Inst); Roche (Inst)
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; pfizer
Consulting or Advisory Role - Biothera; DiaTech Oncology; Kolltan Pharmaceuticals
Research Funding - Genentech/Roche
Consulting or Advisory Role - Bio Connections
Research Funding – Acerta Pharma (Inst); Kite Pharma (Inst); Seattle Genetics (Inst); Novartis (Inst); Amgen (Inst); Allos Therapeutics (Inst); Bristol-Myers Squibb (Inst); Janssen Biotech (Inst); Incyte (Inst); Genentech (Inst); Celgene (Inst)